2010至2019年美国外周血管介入中斑块旋切术使用的全国趋势与变异
基于血管质量倡议登记处,分析2010至2019年因下肢动脉闭塞性疾病行外周血管介入的205377例手术,斑块旋切术使用率从2010年8.5%升至2019年19.7%(趋势P<.0001),17个地理区域间使用率8.2%至29%存在显著差异,最强预测因素为在办公室或门诊中心而非医院环境中行介入。
要点
- 2010至2019年斑块旋切术使用率从8.5%升至19.7%(趋势P<.0001)。
- 17个地理区域间斑块旋切术使用率8.2%至29%存在显著差异。
- 办公室环境行介入的斑块旋切术使用比值比(OR)为10.08(95%CI 9.17-11.09)。
核心结论
- 2010至2019年外周血管介入中斑块旋切术使用显著增加,区域变异大且似乎更多由非临床因素驱动。
研究设计与样本
- 基于血管质量倡议登记处的回顾性分析,纳入2010至2019年因下肢动脉闭塞性疾病行外周血管介入的患者,共205377例手术、152693例独特患者。
主要发现
- 10年间16.6%的外周血管介入手术使用了斑块旋切术,从2010年8.5%增至2019年19.7%(趋势P<.0001)。
- 17个地理区域间斑块旋切术使用率存在显著差异,范围为8.2%至29%。
- 与医院环境相比,办公室环境行外周血管介入的斑块旋切术使用OR为10.08(95%CI 9.17-11.09),门诊中心OR为4.0(95%CI 3.65-4.39)。
- 严重钙化(OR 2.6;95%CI 2.4-2.85)或中度钙化(OR 1.5;95%CI 1.4-1.69)病变更可能使用斑块旋切术。
- 其他预测因素包括择期状态、保险提供方、病变长度、既往外周血管介入、跛行症状和糖尿病。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Small, older studies have suggested that the use of atherectomy devices has become common in peripheral vascular interventions (PVIs) despite the paucity of strong clinical guidelines. We analyzed the 10-year trends in the use of atherectomy for PVIs across the United States and identified the main predictors of atherectomy use. METHODS: Using the Vascular Quality Initiative registry, we identified all patients who had undergone endovascular PVIs for occlusive lower extremity arterial disease from 2010 to 2019. Procedures in which an atherectomy device had been used as the primary or secondary device were classified as the atherectomy group. We calculated the frequency of atherectomy use over time and across geographic regions. Using regression modeling, we identified the factors that were independently associated with atherectomy use. RESULTS: A total of 205,377 PVIs had been performed for 152,693 unique patients. During the 10-year period, 16.6% of the PVI procedures had used atherectomy, increasing from 8.5% in 2010 to 19.7% in 2019 (Ptrend < .0001). Across 17 geographic regions, we found a significant difference in the prevalence of atherectomy use, ranging from 8.2% to 29%. The strongest predictor of atherectomy use was performance of PVI in an office setting (odds ratio [OR], 10.08; 95% confidence interval [CI], 9.17-11.09) or ambulatory center (OR, 4.0; 95% CI, 3.65-4.39) vs a hospital setting. The presence of severe (OR, 2.6; 95% CI, 2.4-2.85) or moderate (OR, 1.5; 95% CI, 1.4-1.69) lesion calcification was also predictive of atherectomy use. Other predictive factors included elective status, insurance provider, lesion length, prior PVI, claudication symptoms, and diabetes mellitus. CONCLUSIONS: Atherectomy use in PVI significantly increased from 2010 to 2019. We found wide regional variability in the use of atherectomy that seemed to be driven more strongly by nonclinical factors.
引用
- Nfor T, Dababneh E, Jan MF, et al. National trends and variability of atherectomy use for peripheral vascular interventions from 2010 to 2019. J Vasc Surg. 2022. PMID: 35367566. doi:10.1016/j.jvs.2022.03.864
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。